History
  • No items yet
midpage
874 F. Supp. 2d 599
E.D. La.
2012
Read the full case

Background

  • MDL governing Vioxx products liability litigation against Merck; Walker asserts CPPA claim arising from Vioxx promotion and purchase; Walker previously dismissed for lack of standing under DC False Claims Act and CPPA; case transferred to MDL for coordinated pretrial matters; Merck moves for judgment on the pleadings seeking dismissal for lack of Article III standing; Walker moves to amend to add a Rule 23 class and address standing deficiencies; court has evaluated sufficiency of economic and statutory injuries and consumer-merchant relationships under CPPA.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Does Walker have Article III standing based on economic injury under CPPA? Walker alleges overpayment/economic injury from Merck's misrepresentation. Merck argues no economic injury from purchasing a product that allegedly worked and caused no personal harm. No sufficient economic injury to establish standing.
Does Walker have Article III standing based on statutory injury under CPPA? Merck violated his statutory right to information under the CPPA.
Walker asserts nexus between Merck's conduct and his rights. Plaintiff lacks direct personal impact and causation linking conduct to him. Statutory injury lacking; no standing.
Is Walker within the CPPA’s consumer-merchant class for standing? Plaintiff asserts broad reach of CPPA and consumer status. Plaintiff does not show he is a consumer-merchant within CPPA's scope. Plaintiff not within CPPA class; no standing.
Would amendment to the complaint be futile on standing grounds? Second Amended Complaint would cure standing deficiencies. Amendment would be futile due to lack of standing and causation. Amendment futile; dismissal affirmed.

Key Cases Cited

  • Rivera v. Wyeth-Ayerst Laboratories, 283 F.3d 315 (5th Cir. 2002) (injury-in-fact required for standing; no such injury here)
  • Williams v. Purdue Pharma Co., 297 F.Supp.2d 171 (D.D.C. 2003) (deceptive advertising without personal injury or receipt of misrepresentation lacks standing)
  • Shaw v. Marriott International, 605 F.3d 1039 (D.C. Cir. 2010) (statutory injury can confer standing if plaintiff is in CPPA class; here not)
  • Grayson v. AT&T Corp., 15 A.3d 219 (D.C. 2011) (standing under CPPA requires identifiable consumer rights; facts insufficient)
  • In re Schering Plough Corp. Intron/Temodar Consumer Class Action, 678 F.3d 235 (3d Cir. 2012) (plaintiff must plausibly link injuries to misrepresentations)
Read the full case

Case Details

Case Name: Vioxx Products Liability Litigation v. Merck & Co.
Court Name: District Court, E.D. Louisiana
Date Published: Jun 13, 2012
Citations: 874 F. Supp. 2d 599; 2012 U.S. Dist. LEXIS 81637; No. MDL 1657
Docket Number: No. MDL 1657
Court Abbreviation: E.D. La.
Log In
    Vioxx Products Liability Litigation v. Merck & Co., 874 F. Supp. 2d 599